Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Therapeutic Efficacy of Montelukast on Anterior STEMl Patients With Primary Percutaneous Coronary Intervention

NCT07320625 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT07320625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07320625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Therapeutic Efficacy of Montelukast on Anterior STEMl Patients With Primary Percutaneous Coronary Intervention
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2026
Completion date
May 1, 2027
Enrollment
512 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction (mi)